
Smoking and Lung Inflammation: Basic, Pre-Clinical and Clinical Research Advances Softcover reprint of the original 1st ed. 2013 Edition
Author(s): Thomas J. Rogers (Editor), Gerard J. Criner (Editor), William D. Cornwell (Editor)
- Publisher: Springer
- Publication Date: 23 Aug. 2016
- Edition: Softcover reprint of the original 1st ed. 2013
- Language: English
- Print length: 220 pages
- ISBN-10: 1493955713
- ISBN-13: 9781493955718
Book Description
Smoking and Lung Inflammation is the first book directly related to chronic lung inflammation of its kind in several respects. First, the it focuses on both basic and clinical research on COPD, and the inflammatory mechanisms that function in these diseases. Second, it is unique with respect to scope of the discussion of the unusual characteristics of the immune response which occurs in these patients. Third, it includes knowledge being gained from translational research conducted through clinical trials at several Medical Schools in the United States. Not only is this research providing information about novel drugs and therapies, but it is also advancing our understanding of the genetics of these diseases. This work will illuminate the molecular basis for these diseases, and hopefully will permit us to individualize the therapies for these diseases.
Editorial Reviews
Review
From the reviews:
“The audience is primarily pulmonologists and basic science investigators with an interest in the aberrant biology related to the inhalation of tobacco smoke. … The book, comprehensively but concisely, addresses the current state of knowledge about smoking and lung inflammation. … The references at the end of each chapter are extensive and relevant.” (Joel C. Seidman, Doody’s Book Reviews, February, 2014)
From the Back Cover
Smoking and Lung Inflammation is the first book directly related to chronic lung inflammation of its kind in several respects. First, the it focuses on both basic and clinical research on COPD, and the inflammatory mechanisms that function in these diseases. Second, it is unique with respect to scope of the discussion of the unusual characteristics of the immune response which occurs in these patients. Third, it includes knowledge being gained from translational research conducted through clinical trials at several Medical Schools in the United States. Not only is this research providing information about novel drugs and therapies, but it is also advancing our understanding of the genetics of these diseases. This work will illuminate the molecular basis for these diseases, and hopefully will permit us to individualize the therapies for these diseases.
Wow! eBook


